Key facts
- Notable investors include 1315 Capital, RC Capital (Cincinnati).
- Status: Acquired/Merged (Operating Subsidiary).
Investors
2- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for Mosaic Diagnostics
- ·The full record, as it builds
Funding rounds
No funding rounds for Mosaic Diagnostics are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Mosaic Diagnostics
Operator of a research-based clinical laboratory intended to provide reliable and understandable scientific analysis. The company offers testing for metabolic, nutritional and toxic factors in chronic conditions such as autism, fibromyalgia and gastrointestinal, and neuropsychiatric disorders, assisting healthcare practitioners in helping children, adults, and families achieve their potential diagnosis through laboratory testing.
- Sector
- Healthcare
- HQ
- Overland Park, KS, United States
- Founded
- 1996
- Employees
- 150
- Website
- mosaicdx.com/
- Ownership
- Acquired/Merged (Operating Subsidiary)
Mosaic Diagnostics doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Mosaic Diagnostics shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Mosaic Diagnostics in its N-PORT filings yet. We sweep new filings monthly.